Physician
Hematology
Dr. Harry S. Menco, MD
|
|
Give Review
Harry S. Menco practices Hematology. Harry S. Menco is a published physician. She has 2 papers published. The most current publication "Mitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL." Doctor Harry S. Menco, MD is registered with Medicare.
Publications
- Mitoxantrone-cyclophosphamide-rituximab: an effective and safe combination for indolent NHL.
- Excellent tolerance of rituximab when given after mitoxantrone/cyclophosphamide: an effective and safe combination for indolent non-Hodgkin's lymphoma.
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
UCLA Medical Center -
University of Amsterdam Faculty of Medicine
Drug Facts
| NPI NUMBER | 1720074099 | |
| NPPES Provider LastName | MENCO | |
| NPPES Provider FirstName | HARRY | |
| NPPES Provider ZIPCode | 913601848 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1359.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 66.0 | |
| Percent Opioid Claims | 4.86 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720074099 |
| Last Name Of The Provider | MENCO |
| First Name Of The Provider | HARRY |
| View All |
Similar Doctors
|
Dr. Samuel J. Slomowitz, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Austin J. Ma, MD |
|
|
Dr. Ashwin M. Sheelvanth, MD
This Doctor is OpenDoctor Recommended.
|